Cancer Treatment Reviews
Volume 36, Issue 4 , Pages 328-334, June 2010

The role of the ‘innovative therapies for children with cancer’ (ITCC) European consortium

  • C. Michel Zwaan

      Affiliations

    • Dept. of Ped Oncology/Hematology, Erasmus MC/Sophia Children’s Hospital, Dr. Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
    • Corresponding Author InformationCorresponding author. Address: Dept. of Ped Oncology/Hematology, Erasmus MC/Sophia Children’s Hospital, Dr. Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands. Tel.: +31 10 703 6691; fax: +31 10 703 1134.
  • ,
  • Pamela Kearns

      Affiliations

    • Institute for Cancer Studies, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Huib Caron

      Affiliations

    • Dept. of Ped Oncology/Hematology, Academic Medical Centre/Emma Children’s Hospital, Amsterdam, The Netherlands
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Arnauld Verschuur

      Affiliations

    • Dept. of Ped Oncology/Hematology, Academic Medical Centre/Emma Children’s Hospital, Amsterdam, The Netherlands
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Riccardo Riccardi

      Affiliations

    • Division of Ped Oncology, Università Cattolica di Roma, Policlinico Universitario A. Gemelli, Rome, Italy
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Joachim Boos

      Affiliations

    • Dept. of Ped Haematology and Oncology, University Children’s Hospital Münster, Münster, Germany
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Francois Doz

      Affiliations

    • Dept. of Ped Oncology, Institute Curie, Paris, France
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Birgit Geoerger

      Affiliations

    • Division of Ped Oncology, Università Cattolica di Roma, Policlinico Universitario A. Gemelli, Rome, Italy
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Bruce Morland

      Affiliations

    • Institute for Cancer Studies, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Gilles Vassal

      Affiliations

    • Division of Ped Oncology, Università Cattolica di Roma, Policlinico Universitario A. Gemelli, Rome, Italy
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • On behalf of the ‘innovative therapies for children with cancer’ European consortium

published online 15 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(10)00028-9

doi:10.1016/j.ctrv.2010.02.008

Cancer Treatment Reviews
Volume 36, Issue 4 , Pages 328-334, June 2010